Endiya Partners Blogs - Thought Leadership in Early-Stage Funding for SaaS, Healthcare, Fintech & Deeptech Startups

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

HealthCare

Dr. Ramesh Byrapaneni

June 4, 2020

COVID-19 drugs: Beyond the low hanging fruit

Given that the pandemic is likely to stay through 2021 and beyond and vaccine development is still at early stages, drugs have a critical role to play in the fight against the COVID-19 virus. Despite anecdotal evidence that some people benefit from drugs such as hydroxychloroquine and azithromycin, favipiravir and remdesivir, more data are needed to confirm their efficacy and safety.

Lifesciences

Dr. Ramesh Byrapaneni

December 19, 2019

Lifesciences 2.0: Genomics

We well understand that genome is the key to understanding an individual at the cellular level along with his or her characteristics, idiosyncrasies and above all medical conditions or the susceptibility to one. If the genes hold the key to an individual’s traits there must be deep information available in them about why and how diseases affect the individual and whether there exists a pattern in the genes of various people who are susceptible to a specific medical condition.

Entrepreneurship & VC

Sateesh Andra

November 22, 2019

Market Creating Innovations – The Founder’s Holy Grail

For Founders in the early stages of their Startup journey, often, there is a lack of clarity about Positioning and Go2Market strategies. It is very important for Founding Teams to have a structured approach on how to Position their products or services based on what problem they are trying to solve and which customer segments they are trying to pursue.

No items found.

Blogs

Filter Blogs